Rafferty Asset Management, LLC Atara Biotherapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$26.7 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$2.8 - $5.46 $169,344 - $330,220	60,480 Added 9.31%	710,258 $2.06 Million
Q4 2022 Feb 13, 2023	SELL	$2.85 - $5.18 $68,402 - $124,325	-24,001 Reduced 3.56%	649,778 $2.13 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $814,649 - $2.5 Million	285,842 Added 73.68%	673,779 $2.55 Million
Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $3,995 - $8,383	852 Added 0.22%	387,937 $3.02 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $16.89 $1.13 Million - $2.27 Million	134,162 Added 53.04%	387,085 $3.6 Million

Q4 2021 Feb 10, 2022	BUY	$14.7 - $19.89 $1.91 Million - $2.59 Million	130,206 Added 106.1%	252,923 $3.99 Million
Q3 2021 Nov 10, 2021	SELL	$11.99 - $17.9 $424,206 - $633,302	-35,380 Reduced 22.38%	122,717 $2.2 Million
Q2 2021 Aug 10, 2021	SELL	$12.89 - $16.58 $503,225 - $647,283	-39,040 Reduced 19.8%	158,097 $2.46 Million
Q1 2021 May 10, 2021	BUY	$14.0 - $20.72 $2.46 Million - $3.64 Million	175,582 Added 814.58%	197,137 $2.83 Million
Q4 2020 Feb 10, 2021	SELL	$12.67 - $26.23 $630,636 - $1.31 Million	-49,774 Reduced 69.78%	21,555 $423,000
Q3 2020 Nov 13, 2020	BUY	$11.92 - $15.87 $419,774 - $558,877	35,216 Added 97.52%	71,329 $924,000
Q2 2020 Aug 07, 2020	BUY	$7.53 - $14.93 $271,930 - $539,167	36,113 New	36,113 $526,000
Q1 2020 May 15, 2020	SELL	$5.69 - $17.78 $359,545 - $1.12 Million	-63,189 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$10.89 - $16.79 $1.08 Million - $1.67 Million	-99,435 Reduced 61.14%	63,189 $1.04 Million
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $518,709 - $859,772	43,118 Added 36.08%	162,624 $2.3 Million
Q2 2019 Aug 09, 2019	BUY	$19.05 - $41.04 $1.04 Million - $2.24 Million	54,607 Added 84.14%	119,506 $2.4 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $41.74 $1.84 Million - $2.71 Million	64,899 New	64,899 $2.58 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account